Since my article "Eli Lilly: The Party Is Probably Nearing The End," in which I expressed my concerns that the hype among retail investors regarding weight-loss drugs has begun to slowly roll down from itsWith over two decades of dedicated experience in investment, Allka Research has been a guiding force for individuals seeking lucrative opportunities. Its conservative approach sets it apart, consistently unearthing undervalued assets within the realms of ETFs, commodities, technology, and pharmaceutical co ...